Moleculin Biotech, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $806.00K.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $18.00K.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $37.00K, a 73.76% decline year-over-year.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for fiscal 2024 was $37.00K, a 82.38% decline from fiscal 2023.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for fiscal 2023 was $210.00K.
- Moleculin Biotech, Inc. stock issued during period, value, new issues for fiscal 2017 was $1.65M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $806.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $18.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $0.00 10-K · filed 2026-03-18 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $37.00K 10-K · filed 2025-03-21 | |
| 2024-03-31 | $37.00K 10-Q · filed 2024-11-08 | |
| 2023-12-31 | $210.00K 10-K · filed 2025-03-21 | |
| 2023-06-30 | $69.00K 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $141.00K 10-Q · filed 2024-11-08 | |
| 2021-06-30 | $1.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $74.68M 10-Q · filed 2022-11-10 | |
| 2020-09-30 | $1.78M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $10.01M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $566.00K 10-Q · filed 2021-11-10 | |
| 2019-09-30 | $52.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $3.58M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $3.23M 10-Q · filed 2020-11-12 | |
| 2018-03-31 | $5.12M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $1.65M 10-K · filed 2019-02-21 | |
| 2016-03-31 | $386.50K 10-Q · filed 2016-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |